Sulfasalazine and Pvt - a phase IV clinical study of FDA data
Summary:
Pvt is reported as a side effect among people who take Sulfasalazine (sulfasalazine), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Plaquenil, and have Gastroesophageal reflux disease.
The phase IV clinical study analyzes which people have Pvt when taking Sulfasalazine. It is created by eHealthMe based on reports of 95,646 people who have side effects when taking Sulfasalazine from the FDA, and is updated regularly.
What is Sulfasalazine?
Sulfasalazine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 96,787 Sulfasalazine users. Check the latest studies of Sulfasalazine.
What is Pvt?
Pvt is found to be associated with 375 drugs and 746 conditions by eHealthMe. Check the latest studies of Pvt.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
95,646 people reported to have side effects when taking Sulfasalazine.
Among them, 16 people (0.02%) have Pvt.

Among these 16 people:
How long have people been on Sulfasalazine when they have Pvt? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 100 %
- 10+ years: 0.0 %
What is the gender of people who have Pvt when taking Sulfasalazine? *
- female: 62.5 %
- male: 37.5 %
What is the age of people who have Pvt when taking Sulfasalazine? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 13.33 %
- 60+: 86.67 %
What are other drugs people take besides Sulfasalazine? *
- Plaquenil: 7 people, 43.75%
- Methotrexate: 6 people, 37.50%
- Enbrel: 5 people, 31.25%
- Pantoprazole: 3 people, 18.75%
- Hydroxychloroquine Sulfate: 3 people, 18.75%
- Prednisone: 2 people, 12.50%
- Spironolactone: 2 people, 12.50%
- Humira: 2 people, 12.50%
- Remicade: 2 people, 12.50%
- Dopamine Hydrochloride: 2 people, 12.50%
What are other side effects people have besides Pvt? *
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 37.50%
- Septic Shock (shock due to blood infection): 2 people, 12.50%
- Gallstones (stone formation by bile component): 2 people, 12.50%
- Escherichia Sepsis (bacterial infection by escherichia coli): 2 people, 12.50%
- Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 2 people, 12.50%
- Hepatic Vein Thrombosis (obstruction in the veins of the liver caused by a blood clot): 2 people, 12.50%
- Acute Hepatic Failure: 2 people, 12.50%
- Application Site Abscess: 1 person, 6.25%
- Ascites (accumulation of fluid in the abdominal cavity): 1 person, 6.25%
- Haematoma (collection of blood outside the blood vessels): 1 person, 6.25%
What are the existing conditions these people have? *
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 6.25%
- High Blood Pressure: 1 person, 6.25%
- Cardiac Failure Congestive: 1 person, 6.25%
- Constipation: 1 person, 6.25%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 6.25%
- Cyclic Vomiting Syndrome (prolonged episodes of severe nausea, vomiting): 1 person, 6.25%
- Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 6.25%
- Depression: 1 person, 6.25%
- Gastric Ulcer (stomach ulcer): 1 person, 6.25%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Sulfasalazine and have Pvt?
- Check whether Pvt is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Sulfasalazine:
- Sulfasalazine (96,787 reports)
Pvt treatments and more:
- Pvt (4,875 reports)
How severe was Pvt and when was it recovered:
Expand to all the drugs that have ingredients of sulfasalazine:
- Pvt and drugs with ingredients of sulfasalazine (19 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sulfasalazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Pvt:
- Pvt (375 drugs)
Browse all the conditions that are associated with Pvt:
- Pvt (746 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on sulfasalazine (the active ingredients of Sulfasalazine) and Sulfasalazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Spironolactone and Fatigue for Women aged 20-29 - 9 seconds ago
- Spironolactone and Weariness for Women aged 20-29 - 9 seconds ago
- Spironolactone and Tiredness for Women aged 20-29 - 9 seconds ago
- Spironolactone and Lethargy for Women aged 20-29 - 10 seconds ago
- Spironolactone and Exhaustion for Women aged 20-29 - 10 seconds ago
- Spironolactone and Exhaustion, Fatigue, Lethargy, Tiredness, Weariness for Women aged 20-29 - 10 seconds ago
- Drug interactions of Fish Oil and Relistor - 16 seconds ago
- Xolair and Diffuse Interstitial Lung Disease for Men aged 50-59 - 24 seconds ago
- Xolair and Idiopathic Pulmonary Pneumonitis (Ipp) for Men aged 50-59 - 24 seconds ago
- Xolair and Diffuse Parenchymal Lung Disease for Men aged 50-59 - 25 seconds ago